Artificial Intelligence | Machine Learning | Machine Perception Metagenomi | AI for Novel Genome Editing Systems


Enterprise, BioTech, Machine Learning, Metagenomics, Big Data , United States

Metagenomi

Artificial Intelligence | Machine Learning | Machine Perception


Metagenomi | AI for Novel Genome Editing Systems

Metagenomi

BioTech, Machine Learning, Metagenomics, Big Data


, United States

Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic diseases.Founded in 2018 by lead metagenomics researchers at UC Berkeley, Brian C. Thomas and Jillian Banfield, Metagenomi is committed to changing the landscape of cell and gene therapies. By using metagenomics to unlock 4 billion years of microbial evolution, Metagenomi is rapidly identifying and characterizing novel nucleases with unique gene editing capabilities. Metagenomi is using this expanded gene editing toolbox to develop game-changing in vivo and ex vivo therapeutics.

 

B2B

26 to 50

Series A

$65,000,000

Scaling Up

2018

 
 

Biotechnology

N/A

Microbial Innovations

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception


Computer Vision Platform

Computer Vision Platform


Image

Image

Video

Video

 

   Software


N/A


Image Algorithm

Image Algorithm

Computer Vision Algorithm

Computer Vision Algorithm

 
 

View All

Scientist

Emeryville, California

 

AI/ML Professionals

Want to work at Metagenomi?

We can introduce you to the right person at Metagenomi

Talk to our Talent Team

 

0

1

$100M

Company was founded 2018 and it took almost 5 years (Jan 2023) to raise first external round

 
 

Date

Round

$ Raised

Investors

01/05/2023

Series B

$100M

Catalio Capital Management, Leaps by Bayer, Moderna Therapeutics, Novo Holdings, SymBiosis LLC

Date : 01/05/2023

Round: Series B

$ Raised: $100M

Investors: Catalio Capital Management, Leaps by Bayer, Moderna Therapeutics, Novo Holdings, SymBiosis LLC

 

Investors

Interested in researching Metagenomi?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Metagenomi

Get Started - Deal Souring Platform

 
Brian Thomas


Brian Thomas
CEO

Cristina Butterfield


Cristina Butterfield
Director of Characterization

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Metagenomi